These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 16720924)

  • 1. Implications of CEA and p53 overexpression in the poor prognosis of colorectal cancer.
    Nasif WA; Lotfy M; El-Sayed IH; El-Kenawy Ael-M; El-Shahat M; El-Hak NG
    Med Oncol; 2006; 23(2):237-44. PubMed ID: 16720924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
    Wu F; Chen L; Wu W; Jiang B; Su X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-dependency of the prognostic effect of carcinoembryonic antigen and p53 protein in colorectal adenocarcinoma.
    Diez M; Pollan M; Müguerza JM; Gaspar MJ; Duce AM; Alvarez MJ; Ratia T; Herñandez P; Ruiz A; Granell J
    Cancer; 2000 Jan; 88(1):35-41. PubMed ID: 10618603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
    Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA
    Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accessing new prognostic significance of preoperative carcinoembryonic antigen in colorectal cancer receiving tumor resection: More than positive and negative.
    Cai Z; Xiao J; He X; Ke J; Zou Y; Chen Y; Wu X; Li X; Wang L; Wang J; Lan P; Wu X
    Cancer Biomark; 2017; 19(2):161-168. PubMed ID: 28128739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 protein accumulation as a prognostic marker in sporadic colorectal cancer.
    Lan YT; Chang SC; Li AF; Lin TC; Chen WS; Jiang JK; Yang SH; Wang HS; Lin JK
    Int J Colorectal Dis; 2007 May; 22(5):499-506. PubMed ID: 17021749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant p53 protein in the serum of patients with colorectal cancer: Correlation with the level of carcinoembryonic antigen and serum epidermal growth factor receptor.
    Abdel-Aziz MM; Lotfy M; El-Kady IM; Abozaid M
    Cancer Detect Prev; 2009; 32(4):329-35. PubMed ID: 16632243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer.
    Gasser M; Gerstlauer C; Grimm M; Bueter M; Lebedeva T; Lutz J; Maeder U; Ribas C; Ribas C; Nichiporuk E; Thalheimer A; Heemann U; Thiede A; Meyer D; Waaga-Gasser AM
    Ann Surg Oncol; 2007 Apr; 14(4):1272-84. PubMed ID: 17211733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of testes-specific protease 50 is associated with poor prognosis in colorectal carcinoma.
    Zheng L; Xie G; Duan G; Yan X; Li Q
    PLoS One; 2011; 6(7):e22203. PubMed ID: 21765952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p53 and Ki-67 as prognostic factors for survival of men with colorectal cancer.
    Lumachi F; Orlando R; Marino F; Chiara GB; Basso SM
    Anticancer Res; 2012 Sep; 32(9):3965-7. PubMed ID: 22993345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of carcinoembryonic antigen prognostic value in serum and tumour tissue of patients with colorectal cancer.
    Li M; Li JY; Zhao AL; He JS; Zhou LX; Li YA; Gu J
    Colorectal Dis; 2009 Mar; 11(3):276-81. PubMed ID: 18513194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of tissue and serum carcinoembryonic antigen in stages I to III of colorectal cancer-A retrospective cohort study.
    Tong G; Xu W; Zhang G; Liu J; Zheng Z; Chen Y; Niu P; Xu X
    Cancer Med; 2018 Nov; 7(11):5327-5338. PubMed ID: 30302946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of carcinoembryonic antigen distribution in tumor tissue of colorectal carcinoma.
    Nazato DM; Matos LL; Waisberg DR; Souza JR; Martins LC; Waisberg J
    Arq Gastroenterol; 2009; 46(1):26-31. PubMed ID: 19466306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical detection of mutant p53 protein in regional lymph nodes is associated with adverse outcome in stage II colorectal cancer.
    Clarke G; Ryan E; Crowe J; O'Keane JC; MacMathúna P
    Eur J Histochem; 1999; 43(4):311-6. PubMed ID: 10682269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Significance of Combined Measurement of p53 Antibody and other Tumor Markers for Colorectal Cancer after Curative Resection.
    Kawahara D; Fujita F; Hayashi H; Matsuyama T; Eguchi S
    Hepatogastroenterology; 2015 May; 62(139):624-8. PubMed ID: 26897942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
    Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
    Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Colorectal Cancer.
    Kunizaki M; Sawai T; Takeshita H; Tominaga T; Hidaka S; To K; Miyazaki T; Hamamoto R; Nanashima A; Nagayasu T
    Anticancer Res; 2016 Aug; 36(8):4171-5. PubMed ID: 27466527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating p53 antibody in patients with colorectal cancer: relation to clinicopathologic features and survival.
    Shiota G; Ishida M; Noguchi N; Oyama K; Takano Y; Okubo M; Katayama S; Tomie Y; Harada K; Hori K; Ashida K; Kishimoto Y; Hosoda A; Suou T; Kanbe T; Tanaka K; Nosaka K; Tanida O; Kojo H; Miura K; Ito H; Kaibara N; Kawasaki H
    Dig Dis Sci; 2000 Jan; 45(1):122-8. PubMed ID: 10695624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas.
    Bosari S; Viale G; Bossi P; Maggioni M; Coggi G; Murray JJ; Lee AK
    J Natl Cancer Inst; 1994 May; 86(9):681-7. PubMed ID: 8158699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.